SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-15-000937
Filing Date
2015-05-14
Accepted
2015-05-14 16:02:51
Documents
12
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q mrns-20150331x10q.htm 10-Q 900234
2 EX-31.1 mrns-20150331ex31180c097.htm EX-31.1 15791
3 EX-31.2 mrns-20150331ex3121cc93f.htm EX-31.2 15965
4 EX-32.1 mrns-20150331ex3210fabe8.htm EX-32.1 9831
5 EX-99.1 mrns-20150331ex991f38812.htm EX-99.1 103733
6 GRAPHIC mrns-20150331ex991f38812g001.jpg GRAPHIC 20436
  Complete submission text file 0001558370-15-000937.txt   3350932

Data Files

Seq Description Document Type Size
7 EX-101.INS mrns-20150331.xml EX-101.INS 385716
8 EX-101.SCH mrns-20150331.xsd EX-101.SCH 15951
9 EX-101.CAL mrns-20150331_cal.xml EX-101.CAL 27883
10 EX-101.DEF mrns-20150331_def.xml EX-101.DEF 41844
11 EX-101.LAB mrns-20150331_lab.xml EX-101.LAB 180484
12 EX-101.PRE mrns-20150331_pre.xml EX-101.PRE 117576
Mailing Address THREE RADNOR CORPORATE CENTER 100 MATSONFORD RD, SUITE 304 RADNOR PA 19087
Business Address THREE RADNOR CORPORATE CENTER 100 MATSONFORD RD, SUITE 304 RADNOR PA 19087 484-801-4670
MARINUS PHARMACEUTICALS INC (Filer) CIK: 0001267813 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36576 | Film No.: 15862764
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences